Prime Medicine to Present at Cowen 43rd Annual Health Care Conference

Rhea-AI Summary

Prime Medicine, a leading biotechnology company listed on Nasdaq under the symbol PRME, announced that Dr. Keith Gottesdiener, President and CEO, will present a corporate overview at the Cowen 43rd Annual Health Care Conference on March 6, 2023, at 9:50 a.m. ET in Boston, MA. This presentation will highlight the company's innovative approach to one-time curative genetic therapies utilizing Prime Editing technology, which can potentially address around 90 percent of disease-causing genetic mutations. A live audio webcast will be available on their website, with a replay accessible for 30 days following the event.

CAMBRIDGE, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that Keith Gottesdiener, M.D., President and Chief Executive Officer of Prime Medicine, will present a corporate overview at the Cowen 43^rd Annual Health Care Conference on Monday, March 6, 2023 at 9:50 a.m. ET in Boston, MA.

A live audio webcast of the presentation will be available under “Events & Presentations” in the News & Events section of the Company’s website at www.primemedicine.com. A replay of the webcast will be available on the Prime Medicine website for 30 days following the presentation.

About Prime Medicine
Prime Medicine is a biotechnology company committed to delivering a new class of differentiated, one-time, curative genetic therapies to address the widest spectrum of diseases. The company is deploying Prime Editing technology, a versatile, precise, efficient and broad gene editing technology, which is designed to make only the right edit at the right position within a gene. With the potential to repair approximately 90 percent of known disease-causing genetic mutations across many organs and cell types, medicines based on Prime Editing could offer a one-time curative genetic therapeutic option to a broad set of patients.

Investor Contact
Hannah Deresiewicz
Stern Investor Relations, Inc.
212-362-1200
hannah.deresiewicz@sternir.com

Media Contact
Dan Budwick, 1AB
dan@1ABmedia.com

FAQ

What will Prime Medicine present at the Cowen 43rd Annual Health Care Conference?

Prime Medicine will present a corporate overview focusing on its innovative one-time curative genetic therapies utilizing Prime Editing technology.

When is Prime Medicine's presentation scheduled during the Cowen Health Care Conference?

The presentation is scheduled for March 6, 2023, at 9:50 a.m. ET.

How can I access the live webcast of Prime Medicine's presentation?

The live audio webcast will be available on Prime Medicine's website under the 'Events & Presentations' section.

How long will the replay of Prime Medicine's presentation be available?

The replay will be available for 30 days following the presentation.

What technology does Prime Medicine focus on for genetic therapies?

Prime Medicine focuses on Prime Editing technology, which allows for precise and efficient gene editing.